NYSE:AGX • US04010E1091
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARGAN INC (AGX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-05 | Lake Street | Downgrade | Buy -> Hold |
| 2025-12-01 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-11-10 | GLJ Research | Upgrade | Hold -> Buy |
| 2025-10-13 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-09-22 | GLJ Research | Initiate | Hold |
| 2025-09-05 | Lake Street | Maintains | Buy -> Buy |
| 2025-07-21 | JP Morgan | Initiate | Neutral |
| 2025-06-05 | Lake Street | Maintains | Buy -> Buy |
| 2025-03-28 | Lake Street | Upgrade | Hold -> Buy |
| 2024-12-06 | CJS Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-12-03 | Lake Street | Downgrade | Buy -> Hold |
| 2024-06-07 | Lake Street | Maintains | Buy -> Buy |
| 2024-04-12 | Lake Street | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 455M -10.68% | 573.333M 26.01% | 874.179M 52.47% | 947.35M 8.37% | 1.213B 28.04% | 1.447B 19.29% | 1.43B -1.17% | |
| EBITDA YoY % growth | 45.4M -19.93% | 38.863M -14.40% | 90.1M 131.84% | 143.03M 58.75% | 186.12M 30.13% | 226.61M 21.75% | N/A | |
| EBIT YoY % growth | 41.7M -20.42% | 36.458M -12.57% | 88.195M 141.91% | 120.29M 36.39% | 160.78M 33.66% | 207.26M 28.91% | 192.1M -7.31% | |
| Operating Margin | 9.16% | 6.36% | 10.09% | 12.70% | 13.25% | 14.32% | 13.43% | |
| EPS YoY % growth | 2.36 -1.67% | 2.39 1.27% | 6.11 155.65% | 8.35 36.60% | 9.65 15.57% | 12.14 25.81% | 11.37 -6.28% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.00 -10.03% | 1.84 14.89% | 2.25 -10.11% | 2.43 12.17% | 2.58 28.95% | 2.13 15.93% | 2.44 8.76% | 2.63 7.88% | 2.99 16.08% |
| Revenue Q2Q % growth | 257.87M 10.92% | 251.89M 30.07% | 294.39M 23.83% | 312.42M 24.39% | 333.4M 29.29% | 284.11M 12.79% | 315.83M 7.28% | 330.57M 5.81% | 364.11M 9.21% |
| EBITDA Q2Q % growth | 37.343M 8.02% | 36.445M 47.21% | 44.01M 42.15% | 52.659M 54.68% | 58.344M 56.24% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 32.417M -0.77% | 31.219M 28.25% | 38.764M 28.98% | 42.083M 28.96% | 42.521M 31.17% | N/A | N/A | N/A | N/A |
All data in USD
9 analysts have analysed AGX and the average price target is 385.36 USD. This implies a price decrease of -6.96% is expected in the next year compared to the current price of 414.2.
ARGAN INC (AGX) will report earnings on 2026-03-25, after the market close.
The consensus EPS estimate for the next earnings of ARGAN INC (AGX) is 2 USD and the consensus revenue estimate is 257.87M USD.
The expected long term growth rate for ARGAN INC (AGX) is 19.52%.